Bulletin
Investor Alert

New York Markets After Hours

Cue Health Inc.

NAS: HLTH

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 17, 2022, 5:29 p.m.

/zigman2/quotes/229642598/composite

$

4.91

Change

-0.08 -1.60%

Volume

Volume 862

Quotes are delayed by 20 min

/zigman2/quotes/229642598/composite

Today's close

$ 4.99

$ 4.99

Change

0.00 0.00%

Day low

Day high

$4.93

$5.18

Open

52 week low

52 week high

$3.70

$22.55

Open

Insider Actions for Cue Health Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
03/30/2022 Ayub Khattak
President and CEO; Director
126,963   Derivative/Non-derivative trans. at $6.7 per share. 850,652
03/30/2022 Clint Sever
Chief Product Officer
99,772   Derivative/Non-derivative trans. at $6.7 per share. 668,472
03/30/2022 Ayub Khattak
President and CEO; Director
292,833   Award at $6.7 per share. 1,961,981
03/30/2022 Ayub Khattak
President and CEO; Director
419,382   Award at $0 per share. 0
03/30/2022 Clint Sever
Chief Product Officer
239,591   Award at $6.7 per share. 1,605,259
03/30/2022 Clint Sever
Chief Product Officer
343,130   Award at $0 per share. 0
03/30/2022 Chris K. Achar
Director
139,635   Award at $0 per share. 0
03/30/2022 John E. Gallagher
Chief Financial Officer
236,090   Award at $0 per share. 0
03/30/2022 Erica Palsis
General Counsel
214,812   Award at $0 per share. 0
03/28/2022 John E. Gallagher
Chief Financial Officer
12,511   Derivative/Non-derivative trans. at $6.99 per share. 87,451
03/24/2022 Ayub Khattak
President and CEO; Director
42,264   Derivative/Non-derivative trans. at $6.99 per share. 295,425
03/24/2022 Clint Sever
Chief Product Officer
34,754   Derivative/Non-derivative trans. at $6.99 per share. 242,930
02/01/2022 Erica Palsis
General Counsel
38,912   Derivative/Non-derivative trans. at $8.78 per share. 341,647
12/28/2021 John E. Gallagher
Chief Financial Officer
17,452   Derivative/Non-derivative trans. at $15.66 per share. 273,298
09/28/2021 ACME Capital
371,293   Award at $12.8 per share. 4,752,550
09/28/2021 Decheng Capital LLC
Director
788,441   Award at $12.8 per share. 10,092,044
09/28/2021 ACME Capital
4,926,417   Derivative/Non-derivative trans. at $0 per share. 0
09/28/2021 ACME Capital
9,619,451   Derivative/Non-derivative trans. at $0 per share. 0
09/28/2021 ACME Capital
4,926,417   Derivative/Non-derivative trans. at $0 per share. 0
09/28/2021 ACME Capital
9,619,451   Derivative/Non-derivative trans. at $0 per share. 0
09/28/2021 Cove Investors I LLC
6,721,714   Derivative/Non-derivative trans. at $0 per share. 0
09/28/2021 Decheng Capital LLC
Director
8,192,468   Derivative/Non-derivative trans. at $0 per share. 0
09/28/2021 Decheng Capital LLC
Director
8,192,468   Derivative/Non-derivative trans. at $0 per share. 0
09/28/2021 Section 32 LLC
3,485,535   Derivative/Non-derivative trans. at $0 per share. 0
09/28/2021 Chris K. Achar
Director
69,710   Derivative/Non-derivative trans. at $0 per share. 0
09/28/2021 ACME Capital
371,293   4,752,550
09/28/2021 John E. Gallagher
Chief Financial Officer
66,379   Derivative/Non-derivative trans. at $18.63 per share. 1,236,640
09/24/2021 Ayub Khattak
President and CEO; Director
976,111   Award at $0 per share. 0
09/24/2021 Clint Sever
Chief Product Officer
798,636   Award at $0 per share. 0
09/24/2021 Chris K. Achar
Director
1,388,246   Award at $0 per share. 0
09/24/2021 Maria Martinez
Director
18,750   Award at $0 per share. 0
09/24/2021 Joanne K. Bradford
Director
18,750   Award at $0 per share. 0
09/24/2021 Carole Faig
Director
18,750   Award at $0 per share. 0

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
7 Purchases
5 Sales
1,885,473
316,264
Last 6 months
7 Purchases
7 Sales
1,885,473
372,628
Last 12 months
25 Purchases
8 Sales
62,389,374
439,007

Officers and Executives

Mr. Ayub Khattak
Chairman & Chief Executive Officer
Mr. David Arida
Chief Operating Officer
Mr. John E. Gallagher
Chief Financial Officer
Mr. Ming hui Gao
Chief Technology Officer
Mr. Chris K. Achar
Director & Chief Strategy Officer
Mr. Glenn Wada
Chief Commercial Officer
Mr. Clint Sever
Chief Product Officer
Dr. Xiang Ming Cui
Director
Ms. Carole Faig
Director
Ms. Joanne K. Bradford
Director
Ms. Maria Martinez
Director
Mr. Nitin Duggal
Chief Marketing Officer
Ms. Elizabeth Swanson
Vice President-People & Culture
Ms. Erica Palsis
General Counsel & Secretary
Mr. Scott Stanford
Independent Director
Link to MarketWatch's Slice.